Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation With the Synaptic Compliant Cryoablation Balloon and System

NCT05905835 is registered in ClinicalTrials.gov with Synaptic Medical Corporation as lead sponsor.

NCT NCT05905835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05905835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation With the Synaptic Compliant Cryoablation Balloon and System
Lead sponsor
Synaptic Medical Corporation
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 20, 2023
Completion date
December 5, 2025
Enrollment
128 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation